Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. Gane, B. Portmann, N. Naoumov, H.M. Smith, J.A. Underhill, P.T. Donaldson, et al.
Long-Term outcome of hepatitis C infection after liver transplantation.
N Engl J Med, 334 (1996), pp. 815-820
[2.]
M. Prieto, M. Berenguer, M. Rayón, J. Córdoba, L. Argüello, D. Carrasco, et al.
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes.
Hepatology, 29 (1999), pp. 250-256
[3.]
M. Berenguer, M. Rayón, M. Prieto, V. Aguilera, D. Nicolás, V. Ortiz, et al.
Are post-transplantation protocol liver biopsies useful in the long-term?.
Liver transplantation, 7 (2001), pp. 790-796
[4.]
C. Feray, L. Caccamo, G.J.M. Alexander, B. Ducot, J. Gugenheim, T. Casanovas, et al.
European Collaborative Study on factors influencing the outcome after liver transplantation for hepatitis C.
Gastroenterology, 117 (1999), pp. 619-625
[5.]
G. Testa, J.S. Crippin, G.J. Netto, R.M. Goldstein, L.W. Jennings, B.S. Brkic, et al.
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
Liver Transpl, 6 (2000), pp. 553-561
[6.]
M. Charlton, E. Seaberg, R. Wiesner, J. Everhart, R. Zetterman, J. Lake, et al.
Predictors of patient and graft survival following liver transplantation for hepatitis C.
Hepatology, 28 (1998), pp. 823-830
[7.]
M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, M. Rayón, et al.
HCV-related fibrosis progression following liver transplantation: increase in recent years.
J Hepatol, 32 (2000), pp. 673-684
[8.]
M. Berenguer, F.X. López-Labrador, T.L. Wright.
Hepatitis C and Liver transplantation.
J Hepatol, 35 (2001), pp. 666-678
[9.]
M. Berenguer, M. Prieto, V. Aguilera, D. Nicolas, D. Carrasco, J. Mir, et al.
Marked decrease in patient survival among HCVinfected patients undergoing liver transplantation in recent years [abstract].
J Hepatol, 34 (2001), pp. 32
[10.]
M. Berenguer, M. Prieto, J.M. Rayón, J. Mora, M. Pastor, V. Ortiz, et al.
Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation.
Hepatology, 32 (2000), pp. 852-858
[11.]
E. Gane, N. Naoumov, K. Qian, M.U. Mondelli, G. Maertens, B.C. Portmann, et al.
A longitudinal analysis of hepatitis C virus replication following liver transplantation.
Gastroenterology, 110 (1996), pp. 167-177
[12.]
S.J. Pelletier, D.P. Raymond, T.D. Crabtree, C.L. Berg, J.C. Iezzoni, Y.S. Hahn, et al.
Hepatitis C-induced hepatic allograft injury is associated with a pre-transplantation elevated viral replication rate.
Hepatology, 32 (2000), pp. 418-426
[13.]
M. Berenguer, F.X. López-Labrador, H.B. Greenberg, T.L. Wright.
Hepatitis C virus and the host: an imbalance induced by immunosuppression.
Hepatology, 32 (2000), pp. 433-435
[14.]
V. DiMartino, F. Saurini, D. Samuel, M. Gigou, E. Dussaix, M. Reynes, et al.
Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
Hepatology, 26 (1997), pp. 1343-1350
[15.]
P.A. Sheiner, M.E. Schwartz, E. Mor, L.K. Schluger, N. Theise, K. Kishikawa, et al.
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation.
Hepatology, 21 (1995), pp. 30-34
[16.]
L. Rostaing, J. Izopet, K. Sandres, J.M. Cisterne, J. Puel, D. Durand.
Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.
Transplantation, 69 (2000), pp. 991-994
[17.]
F.A. Casavilla, J. Rakela, S. Kapur, W. Irish, J. McMichael, A.J. Demetris, et al.
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
Liver Transpl Surg, 4 (1998), pp. 448-454
[18.]
X.A. Zervos, D. Weppler, G.P. Fragulidis, M.B. Torres, J.R. Nery, M.F. Khan, et al.
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
Transplantation, 65 (1998), pp. 1044-1046
[19.]
D.R. Nelson, C. Soldevila-Pico, A. Reed, M.F. Abdelmalek, A.W. Hemming, et al.
The effect of anti-interleukin-2 receptor therapy on the course of hepatitis C recurrence after liver transplantation [en prensa].
Liver Transplantation, (2001),
[20.]
M. Berenguer, M. Prieto, J. Córdoba, M. Rayón, D. Carrasco, V. Olaso, et al.
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
J Hepatol, 28 (1998), pp. 756-763
[21.]
H.R. Rosen, C.R. Shackleton, L. Higa, I.M. Grahek, D.A. Farmer, S.V. McDiarmid, et al.
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Am J Gastroenterol, 92 (1997), pp. 1453-1457
[22.]
X.S. He, B. Rehermann, F.X. López-Labrador, J. Boisvert, R. Cheung, J. Mumm, et al.
Quantitative analysis of hepatitis C virusspecific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.
Proc Natl Acad Sci USA, 96 (1999), pp. 5692-5697
[23.]
H.R. Rosen, D.J. Hinrichs, D.R. Gretch, M.J. Koziel, S. Chou, M. Houghton, et al.
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation.
Gastroenterology, 117 (1999), pp. 926-932
[24.]
C.G. Asanza, C. García-Monzón, G. Clemente, M. Salcedo, L. García-Buey, C. García-Iglesias, et al.
Immunohistochemical evidence of immunopathogenic mechanisms in chronic hepatitis C recurrence after liver trasplantation.
Hepatology, 26 (1997), pp. 755-763
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
